← Latest Filings
K

Kohli Prashant

Chief Executive Officer

Open-market buys
1
$214K total
Open-market sells
0
$0 total
Tracking since
Sep 2026
Open-market buy — $214K
Open-market trades from the last two years.
267,160 Stock Option (Right to Buy) in GRCE
Held directly · as of 2026-08-28
121,357 Common Stock in GRCE
Held directly · as of 2026-09-09
Grace Therapeutics, Inc.
CIK 0001444192